Location History:
- Saitama, JP (2000 - 2001)
- Iruma, JP (1999 - 2006)
- Tokyo, JP (2009 - 2011)
- Osaka, JP (2012 - 2021)
Company Filing History:
5 out of 257 
3 out of 13 
2 out of 198 Years Active: 1999-2021
Title: Koji Teshima: Innovator in Pharmaceutical Development
Introduction
Koji Teshima is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of drugs aimed at treating addiction. With a total of 12 patents to his name, Teshima's work has garnered attention for its innovative approaches to complex medical issues.
Latest Patents
Among his latest patents is a drug designed for treating cocaine addiction or preventing relapse. This invention provides a pharmaceutical solution that contains (R)-2-{3-[1-(5-methyl-1,2,3,4-tetrahydronaphthalen-1-yl)piperidin-4-yl]-2,3-dihydro-2-oxo-benzimidazol-1-yl}-N-methylacetamide or a pharmaceutically acceptable salt thereof. Another notable patent involves a benzimidazole compound that serves as an ORL-1 receptor agonist, which boasts improved bioavailability and metabolic stability compared to conventional compounds.
Career Highlights
Throughout his career, Teshima has worked with notable companies such as Mitsubishi Tanabe Pharma Corporation and Welfide Corporation. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking pharmaceutical innovations.
Collaborations
Teshima has collaborated with esteemed colleagues, including Tetsuro Fujita and Kunitomo Adachi. These partnerships have played a crucial role in advancing his research and development efforts.
Conclusion
Koji Teshima's contributions to pharmaceutical innovation are noteworthy, particularly in the realm of addiction treatment. His patents reflect a commitment to improving medical solutions and enhancing patient care.